Through the activities of the Korean Stem Cell Therapy Association, which was launched in 2008, I have been interested in stem cell therapy and advanced medical approaches in a variety of fields, from beauty to anti-aging for healthy and long life, to chronic diseases and incurable diseases, and have been working hard to incorporate them into clinical practice. With cell therapies from pharmaceutical companies still being problematic at high cost, the clinic has found a more reasonably applicable treatment.

Therefore, we are pleased that the world's first fiber-rich platelets (PRF), which can be called the second generation active platelet-rich plasma (PRP), which is also known as blood stem cells and has developed more effectively the purified platelet-rich plasma (PRP), which is becoming more common, have been developed and can be used for medical treatment. With the results of reporting effective clinical trials through injection procedures for various intractable diseases such as atopy, psoriasis, jaw joint discs, periodontitis, and chronic pain, we hope that it can be used well in the medical practice of the family home in the future.

Recently, Actcellbio has reported that there are clinical results that are effective in medical diseases such as improving liver and blood vessel function, improving heart muscle function, improving varicose vein symptoms, and improving kidney and pancreatic function. We hope that the active cell treatments of Actcellbio. will help many patients suffering from aging and chronic diseases.

I have 30 years of medical experience, and I have been specializing in preventive medicine for 20 years. I studied preventive medicine at Seoul National University Graduate School of Public Health, worked as a guest researcher at IVI (International Vaccine Research Institute), and I am running a hospital with a lot of interest in regenerative medicine.

Recently, in blood stem cell therapy, the effect of activated platelets or blood cells appears immediately compared to inactive cells and regenerates for a long time, and the experience of observing and studying the morphology (morphology) phase changes of academically activated platelets with an electron microscope confirmed that the active and inactive states are clearly different.

This usually measures the activity of NK cells (Natural Killer Cells) during health checkups, and the immunomechanics that protect the body from the outside are proportional to the activity, not the number of NK cells. In the same sense as(https://www.gclabs.co.kr/pr/press/view/5474), platelets are found to be vaguely more important than the number of platelets.

The morphology of platelets activated by electron microscopy shows that when platelets are activated through the activation device, immune substances are activated, and effective treatment is performed in various diseases, showing a clear clinical difference in treatment effect. For this reason, there is a lot of expectation for platelet treatment using the activation device of Actcellbio.

There are several clinical limitations of using platelet-rich plasma (PRP) for a long time, so research to improve this is needed. In 2021, through the Korea Industrial Technology Promotion Association (KOITA), we opened a corporate-affiliated research institute at Gangnam Medical Clinic in Incheon to study the research task name 'Plate Activation Method'.

Platelet-rich fibrin (PRF) is called the second-generation platelet concentrate and is a physical activation method. It has developed a method of activating platelets and white blood cell fibers (the first in the world) using a patented and registered "micro long needle" capillary stress method. In this way, after activating fiber-rich platelets (PRF), which are difficult to inject due to blood hardening, it can be injected (the first in the world) without adding anticoagulants, and it can be treated and treated (pain minimization).

In addition, the existing PRP treatment method with anticoagulants is short in implementation of growth factors for several hours, while activated PRF treatment slowly releases growth factors into the active fiber network for more than 10 days to regenerate tissues. PRF treatment, which can be injected in this way, has been excellent in various treatments such as skin regeneration, pain, dermatitis (psoriasis atopy), jaw joint abnormalities, dental periodontitis, gingivitis, and gum regeneration, and automatically extracting and activating high concentrations of PRP using the activation method has also been effective in treating atopic dermatitis, psoriasis, and lower limb varicose veins, which are difficult to treat due to the release of high concentration of growth factors.

The clinical effectiveness of activating and treating approved bone marrow aspirate, i.e., BMAC (myeloid stem cells), for the first time in the world starting in the first half of 2024 is also expected.